Evidence map›Paper›PMID 20980990›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2011

Serotonin and dopamine play complementary roles in gambling to recover losses.

Daniel Campbell-Meiklejohn, Judi Wakeley, Vanessa Herbert, Jennifer Cook, Paolo Scollo, Manaan Kar Ray, Sudhakar Selvaraj, Richard E Passingham, Phillip Cowen, Robert D Rogers

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 82 citations in OpenAlex.

  1. Dopamine Receptor-Specific Contributions to the Computation of Value.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  2. Trial
  3. In for a penny, in for a pound: methylphenidate reduces the inhibitory effect of high stakes on persistent risky choice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Trial
  4. Modulation of social influence by methylphenidate.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Trial
  5. Trial
  6. Article
  7. Similarities and Differences in Neurobiology.Advances in experimental medicine and biology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  12. Vulnerability and fraud: evidence from the COVID-19 pandemic.Humanities & social sciences communications · 2022
    Article
  13. Article
  14. Article
  15. Selective effects of serotonin on choices to gather more information.Journal of psychopharmacology (Oxford, England) · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. The Role of Tryptophan and Tyrosine in Executive Function and Reward Processing.International journal of tryptophan research : IJTR · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Daniel Campbell-MeiklejohnInteracting Minds, Centre for Functionally Integrative Neuroscience, University of Aarhus, Aarhus, Denmark.
Judi Wakeley
Vanessa Herbert
Jennifer Cook
Paolo Scollo
Manaan Kar Ray
Sudhakar Selvaraj
Richard E Passingham
Phillip Cowen
Robert D Rogers
Warneford Hospital · GBUniversity of Bath · GBUniversity of Oxford · GBAarhus University · DKUniversity of Cambridge · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G0700410
6 · The paper itself

Abstract

Continued gambling to recover losses--'loss chasing'--is a prominent feature of social and pathological gambling. However, little is known about the neuromodulators that influence this behavior. In three separate experiments, we investigated the role of serotonin activity, D(2)/D(3) receptor activity, and beta-adrenoceptor activity on the loss chasing of age and IQ-matched healthy adults randomized to treatment or an appropriate control/placebo. In Experiment 1, participants consumed amino-acid drinks that did or did not contain the serotonin precursor, tryptophan. In Experiment 2, participants received a single 176 μg dose of the D(2)/D(3) receptor agonist, pramipexole, or placebo. In Experiment 3, participants received a single 80 mg dose of the beta-adrenoceptor blocker, propranolol, or placebo. Following treatment, participants completed a computerized loss-chasing game. Mood and heart rate were measured at baseline and following treatment. Tryptophan depletion significantly reduced the number of decisions made to chase losses, and the number of consecutive decisions to chase, in the absence of marked changes in mood. By contrast, pramipexole significantly increased the value of losses chased and diminished the value of losses surrendered. Propranolol markedly reduced heart rate, but produced no significant changes in loss-chasing behavior. Loss chasing can be thought of as an aversively motivated escape behavior controlled, in part, by the marginal value of continued gambling relative to the value of already accumulated losses. Serotonin and dopamine appear to play dissociable roles in the tendency of individuals to gamble to recover, or to seek to 'escape' from, previous losses. Serotonergic activity seems to promote the availability of loss chasing as a behavioral option, whereas D(2)/D(3) receptor activity produces complex changes in the value of losses judged worth chasing. Sympathetic arousal, at least as mediated by beta-adrenoceptors, does not play a major role in laboratory-based loss-chasing choices.

Indexed as

Risk-TakingDopamineFemaleGamblingHumansImpulsive BehaviorMaleReceptors, Dopamine D2Receptors, Dopamine D3SerotoninDopamineReceptors, Dopamine D2Receptors, Dopamine D3Serotonin

Identifiers

PMID20980990
PMCPMC3055672
OpenAlexW2131212709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.